D-0660-2026 Class II Ongoing
FDA drug recall D-0660-2026 was initiated by Lannett Company Inc. on June 26, 2026 and is designated Class II. Reason for recall: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. The recall status is ongoing. Affected quantity: 1392 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- July 8, 2026
- Initiation Date
- June 26, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1392 bottles
Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
Reason for Recall
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Distribution Pattern
US Nationwide.
Code Information
Lot#: 25285401A, Exp. Date: 04/2027